These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

279 related items for PubMed ID: 8549018

  • 1. Clinical experience with acarbose as first line therapy in NIDDM.
    Fölsch UR.
    Clin Invest Med; 1995 Aug; 18(4):312-7. PubMed ID: 8549018
    [Abstract] [Full Text] [Related]

  • 2. Effects of alpha-glucosidase inhibitor (acarbose) combined with sulfonylurea or sulfonylurea and metformin in treatment of non-insulin-dependent diabetes mellitus.
    Vannasaeng S, Ploybutr S, Nitiyanant W, Peerapatdit T, Vichayanrat A.
    J Med Assoc Thai; 1995 Nov; 78(11):578-85. PubMed ID: 8576667
    [Abstract] [Full Text] [Related]

  • 3. Acarbose, an alpha-glucosidase inhibitor for non-insulin-dependent diabetes.
    Welborn TA.
    Med J Aust; 1998 Jan 19; 168(2):76-8. PubMed ID: 9469188
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Clinical experience with an alpha glucosidase inhibitor (acarbose) in the treatment of non-insulin-dependent diabetes. Multicenter study].
    García de los Ríos M, Mujica V, Muñoz S, Durruty P, Larenas G, López MI, Kuzmanic A, Pérez J, Flaskamp R, Cumsille F.
    Rev Med Chil; 1997 Aug 19; 125(8):856-62. PubMed ID: 9580485
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The effect of acarbose on insulin sensitivity in subjects with impaired glucose tolerance.
    Chiasson JL.
    Diabet Med; 1996 Aug 19; 13(3 Suppl 2):S23-4. PubMed ID: 8689858
    [Abstract] [Full Text] [Related]

  • 9. New oral therapies for type 2 diabetes.
    Purnell JQ, Hirsch IB.
    Am Fam Physician; 1997 Nov 01; 56(7):1835-42. PubMed ID: 9371013
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Lowering glycemic index of food by acarbose and Plantago psyllium mucilage.
    Frati Munari AC, Benítez Pinto W, Raúl Ariza Andraca C, Casarrubias M.
    Arch Med Res; 1998 Nov 01; 29(2):137-41. PubMed ID: 9650328
    [Abstract] [Full Text] [Related]

  • 12. Acarbose: its role in the treatment of diabetes mellitus.
    Campbell LK, White JR, Campbell RK.
    Ann Pharmacother; 1996 Nov 01; 30(11):1255-62. PubMed ID: 8913408
    [Abstract] [Full Text] [Related]

  • 13. [Non-insulin-dependent diabetes mellitus associated with nonalcoholic liver cirrhosis: an evaluation of treatment with the intestinal alpha-glucosidase inhibitor acarbose].
    Gentile S, Turco S, Guarino G, Oliviero B, Rustici A, Torella R.
    Ann Ital Med Int; 1999 Nov 01; 14(1):7-14. PubMed ID: 10528419
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Pharmacologic treatment options for non-insulin-dependent diabetes mellitus.
    Tan GH, Nelson RL.
    Mayo Clin Proc; 1996 Aug 01; 71(8):763-8. PubMed ID: 8691897
    [Abstract] [Full Text] [Related]

  • 17. Clinical experience with acarbose: results of a Canadian multicentre study.
    Rodger NW, Chiasson JL, Josse RG, Hunt JA, Palmason C, Ross SA, Ryan EA, Tan MH, Wolever TM.
    Clin Invest Med; 1995 Aug 01; 18(4):318-24. PubMed ID: 8549019
    [Abstract] [Full Text] [Related]

  • 18. Managing therapy and adverse effects with antihyperglycemic agents: a focus on metformin and acarbose.
    Phillips BB.
    Pharm Pract Manag Q; 1997 Oct 01; 17(3):21-31. PubMed ID: 10173308
    [Abstract] [Full Text] [Related]

  • 19. [The use of the alpha-glucosidase inhibitor acarbose for the treatment of type-2 diabetes mellitus in secondary sulfanilamide resistance].
    Gendeleka GF.
    Lik Sprava; 1997 Oct 01; (6):105-7. PubMed ID: 9589946
    [Abstract] [Full Text] [Related]

  • 20. Long-term effect of alpha-glucosidase inhibitor on late dumping syndrome.
    Hasegawa T, Yoneda M, Nakamura K, Ohnishi K, Harada H, Kyouda T, Yoshida Y, Makino I.
    J Gastroenterol Hepatol; 1998 Dec 01; 13(12):1201-6. PubMed ID: 9918426
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.